Tadalafil and Urinary incontinence - a phase IV clinical study of FDA data

Summary:

Urinary incontinence is reported as a side effect among people who take Tadalafil (tadalafil), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Ambrisentan, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Urinary incontinence when taking Tadalafil. It is created by eHealthMe based on reports of 25,126 people who have side effects when taking Tadalafil from the FDA, and is updated regularly.

What is Tadalafil?

Tadalafil has active ingredients of tadalafil. It is often used in erection problems. eHealthMe is studying from 25,550 Tadalafil users. Check the latest studies of Tadalafil.

What is Urinary incontinence?

Urinary incontinence (inability to control the flow of urine and involuntary urination) is found to be associated with 1,631 drugs and 2,518 conditions by eHealthMe. Check the latest studies of Urinary incontinence.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Jul, 27, 2026

25,126 people reported to have side effects when taking Tadalafil.
Among them, 49 people (0.2%) have Urinary incontinence.

Could Tadalafil cause Urinary incontinence?

Among these 49 people:

How long have people been on Tadalafil when they have Urinary incontinence? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 100 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Urinary incontinence when taking Tadalafil? *

  • female: 42.86 %
  • male: 57.14 %

What is the age of people who have Urinary incontinence when taking Tadalafil? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 2.38 %
  • 40-49: 0.0 %
  • 50-59: 16.67 %
  • 60+: 80.95 %

What are other drugs people take besides Tadalafil? *

  1. Ambrisentan: 18 people, 36.73%
  2. Opsumit: 17 people, 34.69%
  3. Uptravi: 10 people, 20.41%
  4. Pantoprazole: 9 people, 18.37%
  5. Vitamin B12: 8 people, 16.33%
  6. Lantus: 8 people, 16.33%
  7. Adcirca: 7 people, 14.29%
  8. Sertraline: 7 people, 14.29%
  9. Triamcinolone: 7 people, 14.29%
  10. Gabapentin: 6 people, 12.24%

What are other side effects people have besides Urinary incontinence? *

  1. Dyspnea (difficult or laboured breathing): 26 people, 53.06%
  2. Fatigue (feeling of tiredness): 20 people, 40.82%
  3. Peripheral Swelling: 16 people, 32.65%
  4. Memory Loss: 15 people, 30.61%
  5. Chest Pain: 15 people, 30.61%
  6. Weight Increased: 14 people, 28.57%
  7. Dyspnea Exertional: 13 people, 26.53%
  8. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 12 people, 24.49%
  9. Headache (pain in head): 11 people, 22.45%
  10. Oedema (fluid collection in tissue): 11 people, 22.45%

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 23 people, 46.94%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 17 people, 34.69%
  3. High Blood Pressure: 14 people, 28.57%
  4. Pain: 12 people, 24.49%
  5. Fluid Retention (an abnormal accumulation of fluid in the blood): 7 people, 14.29%
  6. Gout (uric acid crystals building up in the body): 7 people, 14.29%
  7. Oedema Peripheral (superficial swelling): 7 people, 14.29%
  8. Hyperlipidaemia (presence of excess lipids in the blood): 7 people, 14.29%
  9. Pulmonary Hypertension (increase in blood pressure in the lung artery): 7 people, 14.29%
  10. Diabetes: 7 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Tadalafil and have Urinary incontinence?

- Check whether Urinary incontinence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tadalafil:

Urinary incontinence treatments and more:

How severe was Urinary incontinence and when was it recovered:

Expand to all the drugs that have ingredients of tadalafil:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tadalafil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary incontinence:

Browse all the conditions that are associated with Urinary incontinence:


How the study uses the data?

The study uses data from the FDA. It is based on tadalafil (the active ingredients of Tadalafil) and Tadalafil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: